Application 202116

Type
ANDA
Sponsor
ALVOGEN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL5MGNoNo
002OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL15MGNoNo
003OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL30MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47781-263Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-263Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-263Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-263Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-263Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-264Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-264Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-264Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-264Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-264Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-265Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-265Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-265Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-265Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
47781-265Oxycodone hydrochlorideOxycodone hydrochlorideAlvogen, Inc.ANDACurrent
68071-2536Oxycodone hydrochlorideOxycodone hydrochlorideNuCare Pharmaceuticals,Inc,ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76328ORIG 2023-11-03